Neurofilament light chain as a biological marker for multiple sclerosis: A meta-analysis study

53Citations
Citations of this article
113Readers
Mendeley users who have this article in their library.

Abstract

Purpose: There is a need for biomarkers in multiple sclerosis (MS) to make an early diagnosis and monitor its progression. This study was designed to evaluate the value of neurofilament light (NFL) chain levels as cerebrospinal fluid (CSF) or blood biomarker in patients with MS by using a quantitative meta-analysis. Methods: The PubMed, Embase, and Web of Science databases were systematically searched for relevant studies. Articles in English that evaluated the utility of NFL in CSF and blood in the diagnosis of MS were included. Data were extracted by two independent researchers. Mean (± SD) NFL concentration for MS patients and control subjects were extracted. Review Manager version 5.3 software with a continuous-variable random-effects model was used to summarize the diagnostic indexes from eligible studies. The Newcastle–Ottawa Scale was used for assessing the quality and risk of bias of included studies. In addition, subgroup analysis and meta-regression were performed to assess potential heterogeneity sources. Results: The meta-analysis included 13 articles containing results from 15 studies. A total of 10 studies measured NFL levels in CSF and five studies measured NFL levels in blood. Data were available on 795 participants in CSF and 1,856 participants in blood. Moreover, CSF NFL in MS patients was higher than that in healthy control groups (pooled standard mean difference [Std.MD]=0.88, 95% CI [0.50, 1.26], P<0.00001) and serum NFL in MS patients was higher than that in control subjects (pooled Std.MD=0.47, 95% CI [0.24, 0.71], P<0.0001). Conclusion: NFL chain has significantly increased in MS patients, which substantially strengthens the clinical evidence of the NFL in MS. The NFL may be used as a prognostic biomarker to monitor disease progression, disease activity, and treatment efficacy in the future.

References Powered by Scopus

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

13201Citations
N/AReaders
Get full text

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement

9268Citations
N/AReaders
Get full text

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

7730Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The role of TDP-43 mislocalization in amyotrophic lateral sclerosis

229Citations
N/AReaders
Get full text

Neurofilament light chain as a biomarker in multiple sclerosis

137Citations
N/AReaders
Get full text

The cerebrospinal fluid in multiple sclerosis

136Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Cai, L., & Huang, J. (2018). Neurofilament light chain as a biological marker for multiple sclerosis: A meta-analysis study. Neuropsychiatric Disease and Treatment. Dove Medical Press Ltd. https://doi.org/10.2147/NDT.S173280

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 44

71%

Researcher 11

18%

Professor / Associate Prof. 7

11%

Readers' Discipline

Tooltip

Medicine and Dentistry 30

48%

Neuroscience 20

32%

Biochemistry, Genetics and Molecular Bi... 9

14%

Agricultural and Biological Sciences 4

6%

Article Metrics

Tooltip
Mentions
References: 1
Social Media
Shares, Likes & Comments: 3

Save time finding and organizing research with Mendeley

Sign up for free